News
)
31 May 2024
VIVEbiotech receives the “New Company of Gipuzkoa 2024” award from ADEGI
VIVEbiotech has been awarded the prize “New Company of Gipuzkoa 2024” by ADEGI, Association of Companies of Gipuzkoa.
Read more)
28 May 2024
IBTV interviews Natalia Elizalde during ASGCT´s annual meeting
Natalia Elizalde, Chief Business Development Officer of VIVEbiotech, was interviewed by IBTV during the ASGCT´s annual meeting that took place three weeks ago in...
Read more)
24 May 2024
VIVEbiotech participates at the SLAS Europe 2024 Conference & Exhibition
Juan Camilo Estrada, Head of Analytical Development at VIVEbiotech, will be presenting at the upcoming SLAS Europe 2024 Conference & Exhibition.
Read more)
9 May 2024
VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s Annual Meeting in Baltimore
VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s (ASGCT) Annual Meeting at the Baltimore Convention Center.
Read more)
10 April 2024
VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean
VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean that is taking place these days in the beautiful city of Rome.
Read more)
19 March 2024
VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress
VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress that has just started and will take place today and tomorrow at the ExCel...
Read more)
13 March 2024
VIVEbiotech contributes to a roundtable article in Pharma´s Almanac
VIVEbiotech has contributed to a roundtable article in Pharma's Almanac discussing strategies being employed to accelerate product development and commercialization without compromising quality.
Read more)
6 March 2024
VIVEbiotech receives the EmakumeEkinn award for promoting innovation and female talent
On the occasion of the celebration of International Women's Day, the Sociedad Fomento San Sebastián has made today a recognition to women who contribute...
Read more)
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation (CDTI) have selected it as one of the 40...
Read more)
20 February 2024
Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024
At the end of 2023, Scrip Citeline Commercial gave us the opportunity to provide predictions for the year ahead.
Read more